These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 142584)

  • 1. Anti-complement activities of 2,4-bis(2-hydroxybenzamido)-benzoic acid and its diacetylated derivatives.
    Ohsugi Y; Matsuno T; Takagaki Y
    Chem Pharm Bull (Tokyo); 1977 Jun; 25(6):1202-8. PubMed ID: 142584
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibitory effect of bis(2-hydroxybenzamido) benzoic acid derivatives on reagin-mediated passive cutaneous anaphylaxis (PCA) in rats (author's transl)].
    Ohsugi Y; Takaku S; Mori T; Matsuno T; Shindo M
    Yakugaku Zasshi; 1976 Feb; 96(2):165-9. PubMed ID: 985862
    [No Abstract]   [Full Text] [Related]  

  • 3. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.
    Cochrane CG; Müller-Eberhard HJ; Aikin BS
    J Immunol; 1970 Jul; 105(1):55-69. PubMed ID: 4246566
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of action of an anti-allergic compound; 2,4-bis(2-acetoxy-benzamido) benzoic acid (AB-50): inhibition of anaphylactic and non-anaphylactic histamine release from rat peritoneal mast cells.
    Ohsugi Y; Matsuno T; Takagaki Y
    Chem Pharm Bull (Tokyo); 1977 Sep; 25(9):2437-43. PubMed ID: 73426
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of heparin on the anthus phenomenon].
    Kaiser E; Raab W
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Nov; 134(2):167-80. PubMed ID: 4233320
    [No Abstract]   [Full Text] [Related]  

  • 6. P-selectin requirement for neutrophil accumulation and injury in the direct passive Arthus reaction.
    Santos LL; Huang XR; Berndt MC; Holdsworth SR
    Clin Exp Immunol; 1998 May; 112(2):281-6. PubMed ID: 9649192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic discovery and evaluation of complement inhibitors.
    Bauman N; Brockman JA; Pease BS; Elliott WJ; Colucci DF
    Immunopharmacology; 1981 Dec; 3(4):317-24. PubMed ID: 6460010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of vascular injury at the Arthus reaction site by a complement inhibitor, 5,5',5''-(1,3,6-naphthalene-triyl-tris[sulfonylimino])-tris (1,3-benzene disulfonic acid) hexasodium salt.
    Abdel Mawla MY; Dingemans KP; Amer M; Venneker GT; van Meegen M; Asghar SS
    Complement Inflamm; 1991; 8(1):50-9. PubMed ID: 1828755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new small molecule C5a receptor antagonist inhibits the reverse-passive Arthus reaction and endotoxic shock in rats.
    Strachan AJ; Woodruff TM; Haaima G; Fairlie DP; Taylor SM
    J Immunol; 2000 Jun; 164(12):6560-5. PubMed ID: 10843715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist.
    Strachan AJ; Shiels IA; Reid RC; Fairlie DP; Taylor SM
    Br J Pharmacol; 2001 Dec; 134(8):1778-86. PubMed ID: 11739255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic mechanisms in neutrophil-mediated injury.
    Henson PM
    Am J Pathol; 1972 Sep; 68(3):593-612. PubMed ID: 4262347
    [No Abstract]   [Full Text] [Related]  

  • 12. Alternate complement pathways.
    Osler AG; Sandberg AL
    Prog Allergy; 1973; 17(0):51-92. PubMed ID: 4277357
    [No Abstract]   [Full Text] [Related]  

  • 13. A peptide derived from the parasite receptor, complement C2 receptor inhibitor trispanning, suppresses immune complex-mediated inflammation in mice.
    Inal JM; Schneider B; Armanini M; Schifferli JA
    J Immunol; 2003 Apr; 170(8):4310-7. PubMed ID: 12682267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arthus-type nephritis. I. Characterization of glomerular lesions induced by insoluble and poorly soluble immune complexes.
    Shigematsu H; Niwa Y; Takizawa J; Akikusa B
    Lab Invest; 1979 Apr; 40(4):492-502. PubMed ID: 155176
    [No Abstract]   [Full Text] [Related]  

  • 15. [The immunological activities of dental plaque. (12). Arthus reaction in dental plaque-immunized rabbit gingiva].
    Kunugi H; Isogai H; Ishida M; Sato T; Honda K; Katayama H; Fujita E; Kitano S
    Josai Shika Daigaku Kiyo; 1982; 11(1):22-31. PubMed ID: 6217855
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of hormonal climate on the intensity of the Arthus type immunological reaction].
    Lambotte R; Hustin J
    C R Seances Soc Biol Fil; 1974; 168(1):147-51. PubMed ID: 4279727
    [No Abstract]   [Full Text] [Related]  

  • 17. Arthus-type nephritis. II. Glomerular clearing system against poorly soluble and insoluble immune complexes.
    Shigematsu H; Takizawa J; Akikusa B; Niwa Y
    Acta Pathol Jpn; 1981 May; 31(3):379-89. PubMed ID: 6455902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant soluble human complement receptor type 1 inhibits inflammation in the reversed passive arthus reaction in rats.
    Yeh CG; Marsh HC; Carson GR; Berman L; Concino MF; Scesney SM; Kuestner RE; Skibbens R; Donahue KA; Ip SH
    J Immunol; 1991 Jan; 146(1):250-6. PubMed ID: 1824590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of FUT-175 on rat experimental nephritis. I. Rat Masugi nephritis].
    Kawasaki K; Yaoita E; Yamamoto T; Kihara I
    Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):151-5. PubMed ID: 6748333
    [No Abstract]   [Full Text] [Related]  

  • 20. Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo.
    Moran P; Beasley H; Gorrell A; Martin E; Gribling P; Fuchs H; Gillett N; Burton LE; Caras IW
    J Immunol; 1992 Sep; 149(5):1736-43. PubMed ID: 1380537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.